
FDA posts GH¢70m surplus but warns ageing lab equipment threatens testing capacity
At its 2025 Annual Stakeholders' Meeting, the Authority reported a 51% jump in surplus and a sharp rise in local product registrations, even as officials flagged equipment between eight and 20 years old and a testing backlog that fell short of its 85% coverage target.





